Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Momentum- Dr. Jekyll/Mr. Hyde -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (54)	7/25/2000 12:53:20 PM
From: biowa	Respond to of 55

Rick, However, I'm a trader Acknowledgement is the key to recovery. Now I have two data points <g>. Clinton is supposed to be hosting a conference on pharmaceutical pricing sometime in early August - wouldn't expect that one to be a particular market positive, if the pharma/biotech sector is trending down will the pundits try to pin this one on him as well? Simple rule: Biotech investments are underdamped systems, they get ahead of themselves when everyone expects them to make them rich, then get ridiculously undervalued when everyone realizes the timelines involved. This time the verse has changed from, "We didn't realize it took so long to get a drug approved," to "We didn't realize it would take so long to make sense and use of genomic data." But the tune's the same IMO. That said, this would still be one of the shortest biotech rally's if it really is over. biowa